Search results for “Ipilimumab” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 147 patents, we discovered top 25 key players by total patent application. Bristol Myers Squibb Co., Pfizer Products, Inc., BioInvent International AB are dominant in this area. They take 60.54% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 54
Pfizer Products, Inc.
Connecticut, United States
Patent: 24
BioInvent International AB
Sweden
Patent: 11
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Shanghai Shi, China
Patent: 10
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 8
Pfizer Inc.
New York, United States
Patent: 7
Institut National de Recherche Agronomique SA
France
Patent: 4
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 4
ImmunID SAS
France
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 3 start-ups by total patent application.
STARTUP
Vitroscan B V
Zuid-Holland, Netherlands
Patent: 4
STARTUP
Olivia Newton-John Cancer Research Institute
Victoria, Australia
Patent: 1
STARTUP
Oncoc4 Inc
undefined undefined
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 94 patents applied in the last 5 years. We discover 25 most active companies in this area. The fast-growing Bristol Myers Squibb Co., BioInvent International AB, Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. take 56.38% of patent filing during this period.
Bristol Myers Squibb Co.
New York, United States
Patent: 32
BioInvent International AB
Sweden
Patent: 11
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Shanghai Shi, China
Patent: 10
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
Institut Gustave Roussy EURL
France
Patent: 4
STARTUP
Vitroscan B V
Zuid-Holland, Netherlands
Patent: 4
North Carolina State University
North Carolina, United States
Patent: 4
Pfizer Inc.
New York, United States
Patent: 4
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 3
Institut National de Recherche Agronomique SA
France
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 94 patents in last 5 years, we discover 20 new entrants. BioInvent International AB, Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd., Dana-Farber Cancer Institute, Inc. are the most active new entrants in this area.
BioInvent International AB
Sweden
Patent: 11
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Shanghai Shi, China
Patent: 10
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
Institut Gustave Roussy EURL
France
Patent: 4
North Carolina State University
North Carolina, United States
Patent: 4
STARTUP
Vitroscan B V
Zuid-Holland, Netherlands
Patent: 4
Regents of the University of California
California, United States
Patent: 3
Trillium Therapeutics ULC
Ontario, Canada
Patent: 1
4D Pharma Research Ltd.
Aberdeen City, United Kingdom
Patent: 1
Taiho Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 21 patents, we discovered top 3 universities and scientific research institutions by total patent application.
North Carolina State University
North Carolina, United States
Patent: 4
Institut Gustave Roussy EURL
France
Patent: 4
University of Basel
Basel-Stadt, Switzerland
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: